Cdk7: open questions beyond the prevailing model.
dc.contributor.author | Ganuza, M | en_US |
dc.contributor.author | Santamaría, D | en_US |
dc.date.accessioned | 2020-11-18T14:38:52Z | |
dc.date.issued | 2012-10-01 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/68444 | |
dc.format.extent | 3519 - 3520 | en_US |
dc.language | eng | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Cell Cycle | en_US |
dc.subject | Animals | en_US |
dc.subject | Clinical Trials as Topic | en_US |
dc.subject | Cyclin-Dependent Kinases | en_US |
dc.subject | Enzyme Activation | en_US |
dc.subject | Humans | en_US |
dc.subject | Mice | en_US |
dc.subject | Models, Biological | en_US |
dc.subject | Molecular Targeted Therapy | en_US |
dc.subject | Neoplasms | en_US |
dc.subject | RNA Polymerase II | en_US |
dc.subject | Transcription Factor TFIIH | en_US |
dc.title | Cdk7: open questions beyond the prevailing model. | en_US |
dc.type | Article | |
dc.identifier.doi | 10.4161/cc.21888 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/22935708 | en_US |
pubs.issue | 19 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 11 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |